Diagnosis and monitoring of lung cancer patients by...

Details Diagnosis and monitoring of lung cancer patients by... Diagnosis and monitoring of lung cancer patients by...

G - Physics

01

N

G01N 33/574 (2006.01) G01N 33/577 (2006.01)

Patent

CA 2118759

A method for aiding in the diagnosis of, and monitoring the progression or course of, lung cancer in a patient by measuring the amount of NCA 50/90 in a blood sample, e.g., serum sample, obtained from the patient. Measurement in a single sample of an amount of NCA 50/90 significantly higher than the mean amount of NCA 50/90 in the normal population is an indication of lung cancer in a symptomatic patient. The course of lung cancer can also be monitored by performing a series of specific immunoassays over time to determine changes in the level of NCA 50/90 in blood samples. Increases in blood NCA 50/90 levels over time are indicative of a deteriorating condition whereas decreasing levels of blood NCA 50/90 over time indicate an improving condition.

Affiliated with

Also associated with

Rating

Diagnosis and monitoring of lung cancer patients by... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnosis and monitoring of lung cancer patients by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis and monitoring of lung cancer patients by... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1440821